Back to Search
HAIYAN ZHANG, M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1457617110IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
A133801(CA)
CMS Specialties
PrimaryPATHOLOGY
Education
OTHER
Class of 1997
Research & Publications (20)
BIIB021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance.
PMID 19676042·Int J Cancer·2010
7-preclinical
Discovery and structure-activity relationships of (2-(arylthio)benzylideneamino)guanidines as a novel series of potent apoptosis inducers.
PMID 19282188·Bioorg Med Chem·2009
8-other
Detecting faces in pure noise images: a functional MRI study on top-down perception.
PMID 18185114·Neuroreport·2008
8-other
Discovery and structure-activity relationship of N-phenyl-1H-pyrazolo[3,4-b]quinolin-4-amines as a new series of potent apoptosis inducers.
PMID 17950608·Bioorg Med Chem·2008
8-other
Dimeric ansamycins--a new class of antitumor Hsp90 modulators with prolonged inhibitory activity.
PMID 17131314·Int J Cancer·2007
4-observational
Cascadable all-optical inverter based on a nonlinear vertical-cavity semiconductor optical amplifier.
PMID 17603602·Opt Lett·2007
8-other
Activin modulates the transcriptional response of LbetaT2 cells to gonadotropin-releasing hormone and alters cellular proliferation.
PMID 16772531·Mol Endocrinol·2006
7-preclinical
Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors.
PMID 16451084·J Med Chem·2006
7-preclinical
Identification of new biomarkers for clinical trials of Hsp90 inhibitors.
PMID 16731758·Mol Cancer Ther·2006
7-preclinical
Discovery and structure-activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents.
PMID 16078840·J Med Chem·2005
7-preclinical
Discovery and SAR of indole-2-carboxylic acid benzylidene-hydrazides as a new series of potent apoptosis inducers using a cell-based HTS assay.
PMID 15186849·Bioorg Med Chem·2004
8-other
Targeting multiple signal transduction pathways through inhibition of Hsp90.
PMID 15168026·J Mol Med (Berl)·2004
6-review
Time-of-flight optophoresis analysis of live whole cells in microfluidic channels.
PMID 15307440·Biomed Microdevices·2004
4-observational
Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay.
PMID 14723951·Bioorg Med Chem·2004
8-other
Thermococcoides shengliensis gen. nov., sp. nov., a new member of the order Thermotogales isolated from oil-production fluid.
PMID 19661500·Int J Syst Evol Microbiol·2010
8-other
The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.
PMID 19590950·Breast Cancer Res Treat·2010
8-other
Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer.
PMID 19628330·Cancer Lett·2010
8-other
ADH1A variation predisposes to personality traits and substance dependence.
PMID 19526455·Am J Med Genet B Neuropsychiatr Genet·2010
8-other
Defects in mesenchymal stem cell self-renewal and cell fate determination lead to an osteopenic phenotype in Bmi-1 null mice.
PMID 19653817·J Bone Miner Res·2010
7-preclinical
Theoretical study and rate constants calculation for the reactions of SiH3 radical with SiH3CH3 and SiH2(CH3)2.
PMID 19499539·J Comput Chem·2010
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 222 Escuela Ave, Apt 32
Mountain View, CA 94040 - Phone
- (650) 863-1690
Quick Facts
- NPI
- 1457617110
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile